Visceral fat expresses RBP4 at a higher level than subcutaneous fat, suggesting that RBP4 may be a marker for intra-abdominal fat accumulation, which is thought to exacerbate the underlying pathogenesis of metabolic syndrome [53]. The gene discussed is RBP4; the disease is metabolic syndrome.